This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

4 Stocks Under $5 Making Big Moves


AXT (AXTI), which develops, manufactures and distributes high-performance semiconductor substrates, is trading up 8.2% to $3.03 in recent trading.

Today's Range: $2.91-$3.10

52-Week Range: $2.60-$6.84

Volume: 190,000

Three-Month Average Volume: 148,674

Shares of AXTI are trending higher today after B. Riley recommended adding to AXT postions following the solid fourth quarter report. The firm has a buy rating on the stock with a $4.60 a share price target.

>>4 Tech Stocks Spiking on Big Volume

From a technical perspective, AXTI is exploding higher here right off its 50-day moving average of $2.91 with above-average volume. This move is quickly pushing shares of AXTI within range of triggering a near-term breakout trade. That trade will hit if ATXI manages to take out some near-term overhead resistance levels at $3.10 to $3.14 with high volume.

Traders should now look for long-biased trades in AXTI as long as it's trending above its 50-day at $2.91 and then once it sustains a move or close above those breakout levels with volume that hits near or above 148,674 shares. If that breakout triggers soon, then AXTI will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day of $3.28 or at $3.55 to $3.57. Any high-volume move above $3.57 will then put $4 to $4.14 into range for shares of AXTI.


Durect (DRRX) is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its proprietary drug delivery technology platforms. This stock is trading up 7.5% to $1.14 in recent trading.

Today's Range: $1.08-$1.23

52-Week Range: $0.61-$1.71

Volume: 634,000

Three-Month Average Volume: 384,381

Shares of DRRX are trending higher today in front of its earnings report due out on Thursday, Feb. 28, after the market close.

>>5 Health Care Stocks Triggering Buys

From a technical perspective, DRRX is bouncing hard to the upside here right above both its 50-day at $1.03 and its 200-day at $1.05 with heavy upside volume. This stock has been uptrending strong for the last three months, with shares moving higher from its low of 75 cents to its recent high of $1.25. During that move, shares of DRRX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of DRRX within range of triggering a near-term breakout trade. That trade will hit if DRRX manages to take out some near-term overhead resistance at $1.25 with high volume.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs